Sharp jump seen in drug-resistant pneumonia germs

Monday, March 10th 2003, 12:00 am

By: News On 6

WASHINGTON (AP) _ The United States is seeing a jump in drug-resistant germs and, researchers warn, strains of a dangerous form of strep that can overcome two common antibiotics are expected to multiply.

Overuse of antibiotics may be involved, they said.

By the summer of 2004 as many as 40 percent of the strains of Streptococcus pneumoniae could be resistant to both penicillin and erythromycin. That form of strep causes thousands of cases of meningitis, sinusitis, ear infections and pneumonia every year.

Researchers based at the Harvard School of Public Health studied reports from sites in eight states, measuring how common the drug resistance was in 1996 and how it increased by 1999.

Penicillin resistance rose from 21.7 percent of strep strains in 1996 to 26.6 percent in 1999, and for erythromycin it increased from 10.8 percent to 20.2 percent, the team reports in a paper posted in Monday's online edition of the journal Nature Medicine.

The report provides further support for arguments against unnecessary antibiotic use, said Marc Lipsitch, one of the researchers.

For years, public health experts have warned that overuse of antibiotics _ often when they are not needed _ is leading to more and more drug-resistant bacteria.

For example, many people demand antibiotics when they have a cold, even though colds are caused by viruses, for which antibiotics are ineffective.

Last month the Food and Drug Administration announced plans to require a new warning on antibiotics, pointing out that overusing them makes them less effective.

Doctors must be sure a patient is suffering a bacterial infection, not a virus with similar symptoms, before prescribing antibiotics, the warnings say. The government estimates that half of the 100 million antibiotic prescriptions written each year are unnecessary.

The new research ``puts it on the doctor's plate,'' said Dr. Donald Low of Mount Sinai Hospital in Toronto. ``Can we change the future? Yes, there are things we can do, but can we do them quickly enough?''

Doctors need to make the decision to use antibiotics the right way, in the proper dose, he said, and to encourage vaccination, which reduces illness and thus the need for antibiotics.

Vaccines against that form of strep are recommended for infants and older people, the two groups most likely to get the infection.

Germs resistant to just one of the antibiotics can still be killed by the other, so the researchers project either a slow growth or a decline for these bacteria.

But using a new statistical formula that takes into account how the bacteria are transmitted, the researchers forecast rapid growth for strains of S. pneumoniae that are resistant to both of the antibiotics, reaching 40.6 percent by the summer of 2004. That's up from just 8.6 percent in 1996.

``That's a bit of a chilling message,'' said Low, who was not part of the research team. ``Within a year and a half, we'll know whether they're right or wrong,'' he said. If the technique works, it will be a valuable tool in the future, he added.